AIM Cancellation - Destiny Pharma plc
August 13 2024 - 2:00AM
RNS Regulatory News
RNS Number : 1374A
AIM
13 August 2024
NOTICE
13/08/2024 - 07:00
NOTICE OF
CANCELLATION OF ADMISSION TO TRADING ON AIM
At the request of the company the following
securities have been cancelled from trading on AIM with effect from
the time and date of this notice.
DESTINY PHARMA PLC
|
213800O9WH9Z38EHAC95
|
ORDINARY SHARES OF GBP0.01 EACH, FULLY
PAID
|
(BDHSP57)(GB00BDHSP575)
|
DESY PHAR/PAR VTG FPD
0.01
|
If you have any queries or require further
information, please contact the company's nominated
adviser.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
AMOBSGDIISBDGSD
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Sep 2024 to Oct 2024
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Oct 2023 to Oct 2024